fidaxomicin Articles

Shire's ADHA drug Elvanse accepted for NHS use in Scotland; UK guidance on fidaxomicin

14 May 2013

IQWiG finds no added proven benefit for Astellas' fidaxomicin in Clostridium difficile infection

23 April 2013

AstraZeneca inks deal for Optimer's fidaxomicin in Latin America

4 December 2012

Optimer Pharma could earn $90 million from new Astellas deal

30 March 2012

US FDA advisory panel backs Optimer novel antibiotic Dificid for CDI

7 April 2011

Astellas to pay as much as 165 million euros for right to Optimer’s antibiotic fidaxomicin

8 February 2011

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end